Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (71-80 of 368) with videos related to

Pageof 37
Sort By:
Journal of Viral Hepatitis|July 26, 2021
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysisMohammad T Yousafzai, Sahar Bajis, Maryam Alavi, et al.
The Lancet. Gastroenterology & Hepatology|September 25, 2018
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysisBehzad Hajarizadeh, Evan B Cunningham, Hannah Reid, et al.
Nature Reviews. Gastroenterology & Hepatology|March 18, 2015
Mixed HCV infection and reinfection in people who inject drugs--impact on therapyEvan B Cunningham, Tanya L Applegate, Andrew R Lloyd, et al.
Annals of Internal Medicine|June 30, 2015
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesSoumitri Barua, Robert Greenwald, Jason Grebely, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 20, 2007
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug usersJason Grebely, Jesse D Raffa, Calvin Lai, et al.
The International Journal on Drug Policy|August 23, 2015
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programsSarah Larney, Jason Grebely, Matthew Hickman, et al.
Viruses|July 27, 2022
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, AustraliaMohammad T Yousafzai, Maryam Alavi, Heather Valerio, et al.
The International Journal on Drug Policy|August 12, 2017
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic reviewSahar Bajis, Gregory J Dore, Behzad Hajarizadeh, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Hepatitis C treatment as prevention: evidence, feasibility, and challengesBehzad Hajarizadeh, Jason Grebely, Marianne Martinello, et al.
Addiction (Abingdon, England)|July 22, 2014
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug usersSeonaid Nolan, Viviane Dias Lima, Nadia Fairbairn, et al.
Pageof 37

Showing results (71-80 of 368) with videos related to

Sort By:
Pageof 37
Journal of Viral Hepatitis|July 26, 2021
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysisMohammad T Yousafzai, Sahar Bajis, Maryam Alavi, et al.
The Lancet. Gastroenterology & Hepatology|September 25, 2018
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysisBehzad Hajarizadeh, Evan B Cunningham, Hannah Reid, et al.
Nature Reviews. Gastroenterology & Hepatology|March 18, 2015
Mixed HCV infection and reinfection in people who inject drugs--impact on therapyEvan B Cunningham, Tanya L Applegate, Andrew R Lloyd, et al.
Annals of Internal Medicine|June 30, 2015
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesSoumitri Barua, Robert Greenwald, Jason Grebely, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 20, 2007
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug usersJason Grebely, Jesse D Raffa, Calvin Lai, et al.
The International Journal on Drug Policy|August 23, 2015
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programsSarah Larney, Jason Grebely, Matthew Hickman, et al.
Viruses|July 27, 2022
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, AustraliaMohammad T Yousafzai, Maryam Alavi, Heather Valerio, et al.
The International Journal on Drug Policy|August 12, 2017
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic reviewSahar Bajis, Gregory J Dore, Behzad Hajarizadeh, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Hepatitis C treatment as prevention: evidence, feasibility, and challengesBehzad Hajarizadeh, Jason Grebely, Marianne Martinello, et al.
Addiction (Abingdon, England)|July 22, 2014
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug usersSeonaid Nolan, Viviane Dias Lima, Nadia Fairbairn, et al.
Pageof 37